RNU6-1192P

Across TCGA pan-cancer cohorts, RNU6-1192P RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated RNU6-1192P data layer.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher RNU6-1192P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-1192P expression acts as an unfavorable survival marker.

KIRP and KIRC are the cancer types where RNU6-1192P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	DFS	Tertile	All	0.445	0.914	<.001	54	view →
KIRC	DFS	Tertile	IV	0.127	0.619	.008	48	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

RNU6-1192P–KIRP (DFS)

Open the KIRP breakdown →